The experimental drug Bremelanotide (formerly PT-141) does not act on the vascular system like the former compounds but increases sexual desire and drive in male as well as female. It is applied as a nasal spray. Bremelanotide works by activating melanocortin receptors in the brain. It is currently in Phase IIb trials. super sales of viagra online Buy viagra online canada buy viagra c.o.d viagra pills sale online order order phentermine viagra viagra online canadian pharmacy buy viagra online viagra buy to viagra where viagra for sale viagra in canada viagra pills for sale viagra sample pack check buy viagra canadian pharmacy free viagra order online viagra online canadian pharmacy online viagra viagra The study authors focused on 12 patients who had been diagnosed with chronic obstructive pulmonary disease and were suspected of having PAH. Throughout the study, right heart blood pressure was tracked among all 12 patients by inserting a thin plastic tube into the pulmonary artery -- a procedure known as cardiac catheterization. Cardiac blood pressure was measured at rest and just after all the patients cycled for three minutes. discounted viagra for sale viagra online buy viagra viagra online viagra genericviagra online Yohimbine improves erections for a small percentage of men. It stimulates the parasympathetic nervous system, which is linked to erection, and may increase libido. It is necessary to take the medication for 6 to 8 weeks before determining whether it will work or not. Second, an undescended testicle is more likely to develop a tumor. Testicular cancer affects one of every 2,000 men with undescended testicles. This rate of testicular cancer is higher than the rate in men whose testicles have dropped naturally. When the testicle is inside the scrotum, a man can easily feel his testicles to check for a tumor, or he can be checked by his doctor. This way, any tumor can be found early, when the cancer is easier to cure. Forget Viagra! Sound waves can send your sex life into orbit best price viagra viagra
 
 
Show background image
Thursday, 31 July 2014

Cool Pictures

Shirini Yazdi

Home  >  Media  >  News Release

Parental problems prevent children taking much-needed asthma medication

Vienna, Austria: Parental problems and a chaotic home environment could be preventing children from taking their prescribed asthma medication.

 

A new study, which will be presented today (3 September 2012) at the European Respiratory Society’s Annual Congress in Vienna, has shown that children’s asthma symptoms could be worse due to issues in their home.

 

 

Non-adherence to asthma medication is a common problem, although it is not yet understood what the major barriers are for patients. In this new study, researchers have, for the first time, recorded and analysed a large range of commonly suspected reasons for children taking their asthma medication ineffectively.

 

As part of an on-going project aiming to assess determinants of adherence to asthma, researchers in the Netherlands electronically measured how well children took their maintenance medication to control their asthma. The project has already produced results showing that children with high adherence rates have well-controlled asthma with fewer symptoms, such as breathlessness and wheeze.

 

Despite the testing centre offering patients a comprehensive asthma care programme, many children still had low adherence to asthma medication. To understand what could be preventing children following a treatment plan, researchers conducted in-depth interviews with the parents of 20 children; those with the lowest adherence rates and those with the highest. They compared the results of these interviews with the electronic monitoring rates.

 

Although all parents in the group who had children with low adherence rates expressed the intention to strictly follow the treatment plan at the outset, they failed to do so during the course of the study. When asked about the barriers preventing their child’s adherence to their medication, parents presented a number of lifestyle factors as the reason behind their child did not follow their treatment plan effectively.

 

These factors included chaotic family life, parenting problems, financial problems, or parents being too busy to remember to give their child the medicine in a morning. A further frequent problem was that a number of children between the ages of 8 and 12 years were given full responsibility for taking their medication, without parental support, which often resulted in low adherence.

 

Lead author, Professor Paul Brand, said: “As part of this qualitative study, we have recorded and analysed a number of factors within the home and associated with family lifestyles which could be causing low adherence to asthma medication. It is crucial that healthcare professionals treating children with asthma carefully assess what these potential barriers could be so that appropriate interventions can be put in place to help correct the problems.”

 

David Supple, the parent of an asthma sufferer, said: "Long-standing experience in our household certainly backs this research up. It can be chaotic having four children and when we have given our son, Alex, responsibility over his medication to control his asthma, we have found his adherence slip away. We are conscious of this now and would encourage other parents to keep a close eye on their child’s level of adherence and to spot potential barriers before they become a problem.”

Notes to editors:

  • Abstract: Barriers to adherence to inhaled corticosteroids in a high adherent population of children with asthma
  • Session: 366
  • Date and time: Tuesday 4 September, 10.30-12.45
  • Room: A3


Press Office at ERS Congress in Vienna (Saturday 1st September - Wednesday 5th September 2012):

Lauren Anderson: 0043 6763315356   This e-mail address is being protected from spambots. You need JavaScript enabled to view it

David Sadler: 0043 6767502294

Abstract Print Zone

Browse the electronic book online, print the selected pages or download the full abstract book.

Access it now